Back to device advisories
FDA device recallVulnerabilitiesPublished September 29, 2026

Tandem Diabetes Care, Inc.: Alternate Controller Enabled Insulin Infusion Pump

Updated under an hour ago ()

A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.

Tags
FDA recall, medical device, class 2, Clinical Chemistry, Software Design Change, Open, Classified
Related exam domains
CISSP 3: Security Architecture and Engineering; CISSP 7: Security Operations; CISSP 8: Software Development Security; CISM 3: Information Security Program; CISA 3: Information Systems Acquisition, Development and Implementation; CISA 5: Protection of Information Assets
Source record id
Z-3330-2026
First seen by InfoSec Signals
10/9/2026

Source: openFDA device recalls, U.S. Food and Drug Administration about this source more from it

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.